BDA.AU · Bod Australia Limited

-

Please sign in to comment on BDA.AU

1 Comment

Admin

4 years, 1 month ago

Bod Australia Limited is currently in a long term downtrend where the price is trading 31.0% below its 200 day moving average.

From a valuation standpoint, the stock is 1.6% more expensive than other stocks from the Consumer Defensive sector with a price to sales ratio of 6.9.

Bod Australia Limited's total revenue rose by 58.9% to $3M since the same quarter in the previous year.

Its net income has increased by 8.4% to $-1M since the same quarter in the previous year.

Finally, its free cash flow fell by 82.7% to $-2M since the same quarter in the previous year.

Based on the above factors, Bod Australia Limited gets an overall score of 2/5.

Exchange	AU
CurrencyCode	AUD
ISIN	AU0000181331
Sector	Consumer Defensive
Industry	Household & Personal Products

Beta	1.12
Market Cap	29M
PE Ratio	None
Target Price	None
Dividend Yield	0.0%

ABOUT

Bod Australia Limited

Bod Australia Limited operates as a cannabidiol and medical cannabis healthcare company in Australia, the United Kingdom, the European Union, and the United States. The company operates through three segments: Medical, Over The Counter (OTC) Cannabidiol/Hemp, and OTC Herbals. It engages in the development and manufacture of cannabidiol and hemp products for consumers; and development, manufacture, and distribution of therapeutics medicinal cannabis products for medical markets. The company has a collaboration agreement with Drug Science UK to assess the efficacy of its medicinal cannabis, MediCabilis in managing symptoms associated with the long-term impact of SARS-CoV-2. Bod Australia Limited was incorporated in 2014 and is based in Double Bay, Australia.

BDA.AU · Bod Australia Limited

-

Bod Australia Limited

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Bod Australia Limited using a moving average strategy